CLHIA refutes data in study of rising drug claim costs
Stephen Frank, Canadian Life and Health Insurance Association (CLHIA) President and CEO, has accused Innovative Medicines Canada of using “misleading” data in its recently released study on drug claim costs.
The first part of the study covered factors that drive up claims costs in private drug insurance plans, as reported last week by The Insurance and Investment Journal. The researchers fou...
by Andrea Lubeck Aug. 20, 2018, 1:30 p.m.